5t1l
From Proteopedia
(Difference between revisions)
m (Protected "5t1l" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Cetuximab Fab in complex with CQA(Ph)2DLSTRRLKC peptide== | |
| - | + | <StructureSection load='5t1l' size='340' side='right' caption='[[5t1l]], [[Resolution|resolution]] 2.48Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5t1l]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5T1L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5T1L FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |
| - | [[ | + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=2GX:BETA-PHENYL-L-PHENYLALANINE'>2GX</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr> |
| - | [[Category: Bzymek, K | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4gw1|4gw1]], [[5t1k|5t1k]], [[5t1m|5t1m]]</td></tr> |
| - | [[Category: Williams, J | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5t1l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5t1l OCA], [http://pdbe.org/5t1l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5t1l RCSB], [http://www.ebi.ac.uk/pdbsum/5t1l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5t1l ProSAT]</span></td></tr> |
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Bzymek, K P]] | ||
| + | [[Category: Williams, J C]] | ||
| + | [[Category: Anti-egfr]] | ||
| + | [[Category: Antibody]] | ||
| + | [[Category: Immune system]] | ||
Revision as of 18:50, 26 October 2016
Cetuximab Fab in complex with CQA(Ph)2DLSTRRLKC peptide
| |||||||||||
